This is how I think the recent full approval for Remdesevir potentially could hurt leronlimab. Now that there is an approved drug for covid, EUA's could be off the table. That would force Cytodyn to file a BLA for covid. And we all know how long that could take. However, EUA may still be in play for S/C populations. That would be the logical answer but I'm just so pessimistic about the FDA & BP using every available angle to cock block leronlimab.